Assessing serum chemokines in head and neck cancer patients

  • Research type

    Research Study

  • Full title

    A study assessing levels of chemokines in the serum of patients with head and neck cancer prior to treatment

  • IRAS ID

    198589

  • Contact name

    John Greenman

  • Contact email

    j.greenman@hull.ac.uk

  • Sponsor organisation

    Hull and East Yorkshire NHS R&D

  • Duration of Study in the UK

    0 years, 3 months, 1 days

  • Research summary

    This is a study using stored serum from head and neck cancer patients and healthy volunteers from a previous ethically approved study 05/Q1105/55. The serum is acellular and can therefore be stored with no ethical issues. We are now applying to use the serum samples from that study to determine the concentration of chemokines present. The study will involve the screening of 4 patient samples and 4 healthy controls and then from this specific chemokines will be selected for identification in a cohort of 87 stored serum samples and 23 healthy controls.

  • REC name

    East Midlands - Derby Research Ethics Committee

  • REC reference

    16/EM/0061

  • Date of REC Opinion

    15 Feb 2016

  • REC opinion

    Further Information Favourable Opinion